Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.
about
Retinoids for treatment of Alzheimer's disease5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j miceTaspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangianaAn over expression APP model for anti-Alzheimer disease drug screening created by zinc finger nuclease technologyMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.The secretases: enzymes with therapeutic potential in Alzheimer disease.Decrease in the production of β-amyloid by berberine inhibition of the expression of β-secretase in HEK293 cells.Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugsRevisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-AmyloidCholinergic and glutamatergic drugs in Alzheimer's disease therapy.Assessment of Anticholinesterase Activity of Gelidiella acerosa: Implications for Its Therapeutic Potential against Alzheimer's DiseaseRole of acetylcholinesterase inhibitors in pharmacological regulation of amyloid precursor protein processing.Emerging therapeutics for Alzheimer's disease.Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells.Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.Chemical analysis and acetylcholinesterase inhibitory effect of anthocyanin-rich red leaf tea (cv. Sunrouge).Dramatic increase in readthrough acetylcholinesterase in a cellular model of oxidative stress.Phospholipid transfer protein (PLTP) deficiency accelerates memory dysfunction through altering amyloid precursor protein (APP) processing in a mouse model of Alzheimer's disease.Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.Rapid neurobehavioural analysis based on the effects of an acetylcholinesterase inhibitor from Tephrosia purpurea in ZebrafishHuprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD).ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's disease.Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment.La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.Pharmacophore-based design and discovery of (-)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis.Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.Emerging and potential therapies for Alzheimer's disease
P2860
Q22252919-1F98DD25-F3E4-4EBB-9C92-1B194A91204BQ24564961-84310105-68A6-4F91-A4C6-3DF799FAFEE6Q24598138-62134FD3-34E6-4E3A-8A25-C0169FC07783Q28534870-6038C159-4845-485F-967A-1152EBE80794Q31047131-4E17CE14-7F0A-4871-B9D4-FC3F11A8CDD8Q33887222-2A23E8C0-2CDB-4FA2-B6DD-81360B488B6BQ34094808-49C6AEC0-282F-4B9B-8AFD-1601121F8040Q34327769-E585735A-48D4-46AC-8CCB-A93924E5CDD0Q34749363-75253891-E7A7-456D-8404-7A869C453B4EQ34911093-0891CDE1-BF84-41CB-AEA8-B68F220601C2Q35210180-DF3B5B3D-A390-4F89-84FB-8AB425248D6BQ36257227-89404383-31BA-4CA9-9997-878229538223Q36475062-02C84F47-6C2A-4250-8D33-37F770C90ACEQ36479863-9F30043C-6798-476B-BE9C-B09EF967C27EQ36492347-62B0FD44-32C9-427A-9A19-F0BB5782F30DQ36540223-20979C10-260C-4430-9AFA-010D1ADAF07CQ37211751-2F529C04-32DC-431A-8305-B48BE304A10CQ37233980-D08BC63B-3A95-43D1-BCED-D893BDED50B0Q37461883-82D551A8-611B-4DAB-A09A-8A7997A743E1Q39379536-3EE7A123-CD12-4DF4-B8C7-BA33CC26BE79Q39613009-C96FF445-5254-4919-BB09-9071A7F692BEQ40752006-DA8F4572-A0AF-448A-9D21-4C023CA4E023Q41680485-79AB5E1A-6512-4BB9-BD4B-73A860973054Q41985585-24532832-C362-4AC3-8531-49629BD8FCF3Q44285130-E9F19E4D-500F-42D1-9336-7CB996AE1343Q47728000-ED1294C9-643E-4112-9A90-2BFF6D09C0DBQ47831348-9363F25B-A13A-4F6F-807C-0D1ACD4CDF05Q48396205-DD8F777C-E1D7-4577-9166-20C04A07823CQ50047940-C4052634-ECEC-454B-BFDA-0C2264967ACFQ50678690-B1292D58-1787-45A9-81B2-0E5F68675A44Q51061879-FF9C42CE-7986-428F-9B7C-17E85603D9F3Q56449371-967891C1-3D3C-49A5-829C-E8EBD5A4A05B
P2860
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Acetylcholinesterase inhibitor ...... g in neuroblastoma cell lines.
@en
type
label
Acetylcholinesterase inhibitor ...... g in neuroblastoma cell lines.
@en
prefLabel
Acetylcholinesterase inhibitor ...... g in neuroblastoma cell lines.
@en
P2093
P50
P1476
Acetylcholinesterase inhibitor ...... ng in neuroblastoma cell lines
@en
P2093
Alessandro Padovani
Barbara Borroni
Elena Marcello
Flaminio Cattabeni
P304
P356
10.1111/J.1471-4159.2004.02680.X
P407
P577
2004-09-01T00:00:00Z